Allarity Therapeutics A/S — Credit Rating and Financial Key Figures

Allarity Therapeutics A/S (CVR number: 28106351) is a company from RUDERSDAL. The company recorded a gross profit of 28 kDKK in 2023. The operating profit was 28 kDKK, while net earnings were -406 kDKK. The profitability of the company measured by Return on Assets (ROA) was 70.5 %, which can be considered excellent but Return on Equity (ROE) was -142.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 20 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Allarity Therapeutics A/S's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.